FeedVax develops oral vaccines for farmed fish, eliminating the need for handling during vaccination, which reduces stress for both animals and producers. This approach addresses the reliance on antibiotics in aquaculture, promoting healthier fish and more sustainable production practices.
Funding
$800K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods of vaccinating farmed fish require manual handling, causing stress to the animals and increasing labor costs for producers. This also contributes to the overuse of antibiotics in aquaculture, which poses risks to both animal and human health.
Solution
FeedVax offers a platform of oral vaccines for farmed fish, administered through feed, which eliminates the need for individual handling during vaccination. This reduces stress on the fish, lowers labor costs for producers, and promotes healthier, more sustainable aquaculture practices. By replacing injectable vaccines with an oral delivery system, FeedVax aims to minimize antibiotic use and improve overall animal welfare. The company's approach focuses on creating a simple, practical, and profitable solution for transforming animal production.
Target Audience
FeedVax targets aquaculture producers seeking to improve animal welfare, reduce labor costs, and minimize antibiotic use in their operations.
Features
- Oral vaccine platform for fish administered through feed
- Eliminates the need for manual handling during vaccination
- Reduces stress on fish and lowers labor costs
- Promotes healthier and more sustainable aquaculture practices
- Reduces the reliance on antibiotics